A clinical pharmacological study (270 patients) was made to optimize therapy of epilepsy with carbamazepines (finlepsin and its retard form). It was established that insufficient (standard) doses of finlepsin are often used, serum levels of the drug are not estimated, drug pharmacokinetics is not taken into account, maximum permissible doses of the drug are not reached. Estimation of the efficiency of both preparations in the treatment of various types of the seizures was carried out. The advantages of finlepsin-retard were demonstrated.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
[the optimization
4
optimization epilepsy
4
epilepsy therapy
4
therapy finlepsin]
4
finlepsin] clinical
4
clinical pharmacological
4
pharmacological study
4
study 270
4
270 patients
4
patients optimize
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!